Výsledky vyhledávání - "Rizos, C. V."

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia

Autor: Florentin, M., Liberopoulos, E. N., Moutzouri, E., Rizos, C. V., Tselepis, A. D., Elisaf, M. S.

Objective: To compare the effects of simvastatin alone versus simvastatin plus ezetimibe on small dense low-density lipoprotein cholesterol (sdLDL-C) concentration in subjects with primary hypercholesterolemia. Research design and methods: Patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::248aacb1c063940275ca10ab6bcaa11f
http://olympias.lib.uoi.gr/jspui/handle/123456789/9608

Zobrazit plný text záznamu

Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-gamma activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A

Autor: Rizos, C. V., Liberopoulos, E. N., Tellis, C. C., Florentin, M., Elisaf, M. S., Tselepis, A. D.

BACKGROUND: Rosuvastatin reduces low-density lipoprotein cholesterol (LDL-C) and plasma lipoprotein-associated phospholipase A (Lp-PLA) Some sartans partially activate peroxisome proliferator-activated receptor-gamma (PPARgamma), possibly having a fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::e5ee86bf000ba37110d15464465700c4
http://olympias.lib.uoi.gr/jspui/handle/123456789/22960

Zobrazit plný text záznamu

THE EFFECTS OF COMBINING ROSUVASTATIN WITH SARTANS OF DIFFERENT PPAR gamma ACTIVATING CAPACITY ON LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2)

Autor: Rizos, C. V., Liberopoulos, E. N., Tellis, C. C., Florentin, M., Elisaf, M. S., Tselepis, A. D.

Atherosclerosis Supplements

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::37886b7140bda7a430e47e4c999b7bd3
http://olympias.lib.uoi.gr/jspui/handle/123456789/9615

Zobrazit plný text záznamu

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study

Autor: Rizos, C. V., Milionis, H. J., Kostapanos, M. S., Florentin, M., Kostara, C. E., Elisaf, M. S., Liberopoulos, E. N.

BACKGROUND: Statin therapy has been reported to be associated with new-onset diabetes. Angiotensin II-receptor blockers (ARBs) are effective antihypertensive drugs that have been reported to activate peroxisome proliferator-activated receptor gamma (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::eec6c2a58bb75a6360a17c2aacad4680
http://olympias.lib.uoi.gr/jspui/handle/123456789/22059

Zobrazit plný text záznamu

Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia

Autor: Florentin, M., Tselepis, A. D., Elisaf, M. S., Rizos, C. V., Mikhailidis, D. P., Liberopoulos, E. N.

Small, dense low density lipoprotein (sdLDL) particles are considered an emerging cardiovascular risk factor. Obese patients with mixed dyslipidaemia frequently have elevated sdLDL cholesterol (sdLDL-C) levels. Therefore, agents that favourably modul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::7869f4dfa35a29cb1b8c4e2e990cc641
http://olympias.lib.uoi.gr/jspui/handle/123456789/10520

Zobrazit plný text záznamu

Are the pleiotropic effects of telmisartan clinically relevant?

Autor: Rizos, C. V., Elisaf, M. S., Liberopoulos, E. N.

Hypertension is one of the major risk factors for cardiovascular disease. Angiotensin receptor blockers (ARBs) are a class of antihypertensive drugs with established efficacy and favorable safety profile. Telmisartan, a member of the ARB family, hold

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::e418175d32bf91422d9c2670260b1f36
http://olympias.lib.uoi.gr/jspui/handle/123456789/23724

Zobrazit plný text záznamu

Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose

Autor: Kostapanos, M. S., Milionis, H. J., Agouridis, A. D., Rizos, C. V., Elisaf, M. S.

AIM OF THE STUDY: The increase in physician-reported diabetes following rosuvastatin treatment in the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin study has raised concerns whether this statin exer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::97df3b238ee11de7861f0786330cbd08
http://olympias.lib.uoi.gr/jspui/handle/123456789/18489

Zobrazit plný text záznamu

How safe is the use of thiazolidinediones in clinical practice?

Autor: Rizos, C. V., Elisaf, M. S., Mikhailidis, D. P., Liberopoulos, E. N.

BACKGROUND: Thiazolidinediones (TZDs) are widely used antidiabetic drugs with proven efficacy regarding mainly surrogate markers of diabetes management. However, efficacy on surrogate markers may not always translate into benefits in clinical outcome

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::d1b6e99e24198956bd3cc6c79ff78e03
http://olympias.lib.uoi.gr/jspui/handle/123456789/21159

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání